CDC Endorses Antibiotic 'Morning After Pill' to Combat STDs

The CDC has issued new guidelines recommending the antibiotic doxycycline as a post-exposure prophylaxis (Doxy-PEP) to prevent STDs, particularly targeting gay and bisexual men and transgender women. The drug, to be taken within 72 hours of unprotected sex, could prevent up to 70% of chlamydia and syphilis infections and 50% of gonorrhea cases. This measure aims to combat the rising STD epidemic in the US, although concerns about antibiotic resistance and side effects remain.